ViroMed Co Ltd

KO:084990 Korea
Market Cap
$37.86K
₩55.43 Million KRW
Market Cap Rank
#42821 Global
#2393 in Korea
Share Price
₩5950.00
Change (1 day)
+0.00%
52-Week Range
₩2185.00 - ₩8500.00
All Time High
₩167270.44
About

ViroMed Co Ltd operates in various business sectors.

Market Cap & Net Worth: ViroMed Co Ltd (084990)

ViroMed Co Ltd (KO:084990) has a market capitalization of $37.86K (₩55.43 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #42821 globally and #2393 in its home market, demonstrating a -2.78% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying ViroMed Co Ltd's stock price ₩5950.00 by its total outstanding shares 9316 (9.32K).

ViroMed Co Ltd Market Cap History: 2015 to 2026

ViroMed Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $606.78K to $37.86K (-20.74% CAGR).

ViroMed Co Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how ViroMed Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of 084990 by Market Capitalization

Companies near ViroMed Co Ltd in the global market cap rankings as of March 18, 2026.

Key companies related to ViroMed Co Ltd by market ranking:

  • MONROE CAP.CORP. DL -001 (F:6JT): Ranked #42812 globally with a market cap of $37.39K USD ( €36.42K EUR).
  • Sonovia Ltd (TA:SONO): Ranked #42813 globally with a market cap of $37.36K USD ( ILA13.93 Million ILA).
  • TELESTE (BE:TS6): Ranked #42822 globally with a market cap of $37.09K USD ( €36.13K EUR).
  • GOGO (G0G.SG) (STU:G0G): Ranked #42823 globally with a market cap of $37.09K USD ( €36.13K EUR).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#42812 MONROE CAP.CORP. DL -001 F:6JT $37.39K €3.93
#42813 Sonovia Ltd TA:SONO $37.36K ILA48.60
#42822 TELESTE BE:TS6 $37.09K €3.64
#42823 GOGO (G0G.SG) STU:G0G $37.09K €3.90

ViroMed Co Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, ViroMed Co Ltd's market cap moved from $606.78K to $ 37.86K, with a yearly change of -20.74%.

Year Market Cap Change (%)
2026 ₩37.86K -4.34%
2025 ₩39.57K +130.37%
2024 ₩17.18K -56.24%
2023 ₩39.26K -41.52%
2022 ₩67.12K -53.52%
2021 ₩144.43K -24.33%
2020 ₩190.88K -52.57%
2019 ₩402.48K -53.52%
2018 ₩865.86K +55.54%
2017 ₩556.67K +57.78%
2016 ₩352.82K -41.85%
2015 ₩606.78K --

End of Day Market Cap According to Different Sources

On Mar 18th, 2026 the market cap of ViroMed Co Ltd was reported to be:

Source Market Cap
Yahoo Finance $37.86K USD
MoneyControl $37.86K USD
MarketWatch $37.86K USD
marketcap.company $37.86K USD
Reuters $37.86K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.